Riga, Latvia, 28 August 2023 – MGI, a global leader in life science technology, is pleased to announce the launch of its new digital ecosystem to empower customers and partners across the Europe-Africa region. The initiative includes a new regional website, mgi-tech.eu, the “Genomics Unlocked” learning and webinar platform, genomicsunlocked.com, targeted email marketing campaigns, and a private distributor portal for internal training.
“We have always put our customers and partners first, and this new ecosystem is a way for MGI to deliver greater value by expanding our online presence and facilitating engagement within our virtual community,” said Dr Yong Hou, General Manager of MGI Europe and Africa. “We look forward to providing region-specific product and service updates, knowledge and applications of our technology, and more to enrich our customers’ experience with MGI.”
The regional site, which went live today, features information on products available in the EU&AF region and a scientific blog sharing first-hand experiences with MGI technology and publications from MGI experts. A training hub for customers and students, offering learning resources on high-throughput sequencing products and applications, and an e-commerce system for distributors will be rolled out in Q4 2023 and 2024 respectively. These features will help users explore MGI offerings more easily and improve the overall user experience.
The “Genomics Unlocked” platform, launched in June, offers customers, partners, and employees worldwide early access to webinar invites and on-demand content. Designed to highlight the power of genomics research and expert insights, the platform will host at least 10 expert sessions this year covering a broad range of topics, including agriculture, genetic disorders, oncology, pathogens, Stereo-seq, population genomics, and the latest technological breakthroughs and instruments.
Other elements of the regional digital ecosystem include quarterly email campaigns to share news, increase brand awareness, and strengthen engagement with customers and partners. An internal distributor portal will also be introduced this year, featuring video lectures, quizzes, and tests to help users better understand MGI’s state-of-the-art platforms and technologies.
Since opening its facilities in Riga, Latvia in November 2019, MGI has steadily expanded operations in the EU&AF region. The company has established a central office in Wehrheim, Germany, a Customer Experience Center (CEC) in Riga, and two additional CECs in London, United Kingdom, in collaboration with Imperial College London, and in Berlin, Germany, with ALACRiS Theranostics GmbH, both established in 2022.
About MGI
MGI Tech Co., Ltd. (or its affiliates, “MGI”), headquartered in Shenzhen, China, is committed to developing core tools and technology to lead life science through intelligent innovation. Leveraging proprietary technology, MGI focuses on research & development, production, and sales of sequencing instruments*, reagents*, and related products to support life science research, agriculture, precision medicine, and healthcare.
As of 30 June 2023, MGI employs over 2,800 people, 35.2% of whom are engaged in R&D. Founded in 2016, MGI operates in more than 90 countries and regions, serving over 2,400 customers. For more information, visit the MGI website
or connect on Twitter, LinkedIn, or YouTube.
Products are for Research Use Only. Not for use in diagnostic procedures unless specifically noted.
